Ibrutinib 140mg Archives | Tagrix 80mg (Osimertinib), Osimert 80mg (Osimertinib), Osicent 80mg (Osimertinib), Olanib-50/150 mg (Olaparib), Osimert 80mg (Osimertinib), Caboxen 20mg (Cabozantinib), Ibruxen Capsule 140mg (Ibrutinib 140mg), Avalet 20mg (Avatrombopag), Rutinib Cream 30 (Ruxolitinib), Ponatinix 45mg (Ponatinib), Elbonix 50mg & Elbonix 25mg (Eltrombopag ), Crizocent 250 Mg (Crizotinib), Sotoxen 120mg (Sotorasib), Lorbrexen 100 Mg (Lorlatinib) provider in the world.

Quick View
- Quick View
- Anti Cancer, Leukemia
- Ibruxen Capsule 140mg (Ibrutinib 140mg)
- Ibrutinib is a small-molecule inhibitor of BTK. Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity. BTK is a signaling molecule of the B-cell antigen receptor (BCR) and cytokine receptor pathways. BTK’s role in signaling through the B-cell surface receptors results in activation of pathways necessary for B-cell…
- Read more